All In MedTech

FDA Clearance Tracker · P020014-S018

CONCEPTUS ESSURE SYSTEM FOR PERMANENT BIRTH CONTROL

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 16, 2009 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 16, 2009

Approved

Time to decision

293 days

Received May 27, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P020014-S018
Device name
CONCEPTUS ESSURE SYSTEM FOR PERMANENT BIRTH CONTROL
Applicant location
Berlin
Received
May 27, 2008
Decided
Mar 16, 2009
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P020014

Device type

Device class
Class III
Regulation
21 CFR 884.5380

Every decision under product code HHS

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Bayer Pharma AG

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.